Type 2 Diabetes - Participants Who Have Never Received Insulin - Laredo TX

Summary:

ONWARDS is a global programme of clinical studies to investigate how well a new investigational insulin taken once weekly, insulin icodec, controls blood sugar in people with diabetes.

Once-weekly insulin icodec will be compared with insulins taken daily, which are already available on the market.

As part of the programme, this study is comparing the effectiveness and safety of once-weekly insulin icodec with that of daily insulin over a period of 14 months.

Qualified Participants Must:

• You may qualify for this study if you are an adult with type 2 diabetes who has not yet received insulin treatment.

Qualified Participants May Receive:

Have you considered participating in a clinical study? This could be your chance to:

·       Take a more active role in managing your diabetes.

·       Help others by contributing to medical research.

You could be part of a clinical study programme that helps regulatory authorities decide if a new long-acting insulin treatment should be made available for people with type 2 diabetes.